إعلان
إعلان
MAZE
Maze Therapeutics, Inc. Common Stock
40.31
USDبرعاية
+1.36
+3.49%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
40.30
-0.02
-0.04%
تقارير أرباح MAZE
النسبة الإيجابية المفاجئة
MAZE تفوق 2 من 4 آخر التقديرات.
50%
التقرير التالي
بيانات التقرير القادم
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/--
التغير الضمني من Q-- -1 (Revenue/ EPS)
--
/--
Maze Therapeutics, Inc. Common Stock earnings per share and revenue
On ٠٦ نوفمبر ٢٠٢٥, MAZE reported earnings of -0.66 USD per share (EPS) for Q3 25, beating the estimate of -0.72 USD, resulting in a 8.68% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -3.48% price change (close before vs. close after earnings).
Looking ahead to -- --, -- المحللين forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
الأسئلة الشائعة
What were Maze Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Maze Therapeutics, Inc. Common Stock reported EPS of -$0.66, beating estimates by 8.68%, and revenue of $0.00, 0% as expectations.
How did the market react to Maze Therapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -3.48%, changed from $29.63 before the earnings release to $28.60 the day after.
When is Maze Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Maze Therapeutics, Inc. Common Stock's next earnings report?
Based on --
المحللين, Maze Therapeutics, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان